Type of Hospital Doesn't Impact Thrombolysis Outcomes in Stroke

This article originally appeared here.
Share this content:
Type of Hospital Doesn't Impact Thrombolysis Outcomes in Stroke
Type of Hospital Doesn't Impact Thrombolysis Outcomes in Stroke

FRIDAY, June 9, 2017 (HealthDay News) -- For older adults with acute stroke, treatment with intravenous thrombolysis (IVT) is associated with similar outcomes, irrespective of hospital characteristics, according to a study published online June 2 in the Journal of the American Geriatrics Society.

Francisco Purroy, M.D., Ph.D., from the Hospital Universitari Arnau de Vilanova de Lleida in Spain, and colleagues conducted a prospective registry study involving 3,231 individuals with stroke treated only with IVT (36.8 percent aged ≥80 years). At three months, the authors evaluated symptomatic intracranial hemorrhage, mortality, and favorable outcome according to hospital characteristics. Hospitals were classified as comprehensive stroke centers (CSCs), primary stroke centers (PSCs), and community hospitals operating a telestroke system (TS).

Among participants aged 80 years and older, the researchers found that 90-day mortality was 23.2 percent, and 38.7 percent had favorable outcomes at three months. Overall, 4.7 percent of subjects had symptomatic intracranial hemorrhage (SICH). There was no significant difference in risk factors between participants treated in different types of hospitals, nor was there any difference in basal stroke severity measured according to National Institute of Health Stroke Scale scores. Similar outcomes were achieved by the different types of hospitals, although the proportion of SICH was significantly higher at TS and PSC hospitals than at the CSC (6.3 and 6.3, respectively, versus 3.2 percent).

"Older adults with acute stroke treated with IVT had similar outcomes regardless of hospital characteristics," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Zika Does Not Appear to Last in Semen As Long As Thought

Zika Does Not Appear to Last in Semen ...

More research is needed to better inform public health recommendations

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke ...

I-131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke

Higher Odds of Infection With Reduced Kidney Function

Higher Odds of Infection With Reduced Kidney Function

Study finds excess community-acquired infections incidence in individuals with mild to severe CKD

is free, fast, and customized just for you!

Already a member?

Sign In Now »